NASDAQ:BLFS
Biolife Solutions Inc.
Biolife Solutions Inc.'s revenue grew 28.9% in fiscal 2025 to $96.2M while operating margin fell to −17.3%. Free cash flow was $10.6M, 11.1% of revenue, and the diluted share count rose 5.6%.Summary generated from Biolife Solutions Inc.'s SEC filings. Latest annual report filed Feb 26, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$96.2M
Revenue growth+28.9%
Revenue, 5-yr CAGR+14.9%
Gross margin64.6%
Operating margin−17.3%
Net margin−4.8%
ROIC−4.3%
Return on equity−1.3%
Debt / equity0.01
Free cash flow$10.6M
FCF margin11.1%
Share count change+5.6%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 119 | 76 | 68 | 75 | 96 |
| Operating income | −35 | −6 | −17 | −4 | −17 |
| Net income | −9 | −140 | −68 | −20 | −5 |
| Free cash flow | −13 | −19 | −19 | 5 | 11 |
Recent filings
- 4Insider transaction report
Oct 8, 2026 - 4Insider transaction report
Oct 8, 2026 - 8-KCompletion of an acquisition or disposition
Oct 6, 2026 - 8-KOther events
Sep 9, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 6, 2026 - 8-KResults of operations and financial condition
Aug 6, 2026 - 8-KRegulation FD disclosure
Aug 3, 2026 - 8-KEntry into a material agreement
Jul 22, 2026